Abstract
During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Current Organic Synthesis
Title: From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis
Volume: 8 Issue: 6
Author(s): Katharina Bica, Sonja Leder and Peter Gaertner
Affiliation:
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Abstract: During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Export Options
About this article
Cite this article as:
Bica Katharina, Leder Sonja and Gaertner Peter, From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis, Current Organic Synthesis 2011; 8 (6) . https://dx.doi.org/10.2174/1570179411108060824
DOI https://dx.doi.org/10.2174/1570179411108060824 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Senescent Mesenchymal Stem Cells in Systemic Lupus Erythematosus
Current Signal Transduction Therapy Type 2 Diabetes, Insulin Secretion and β-Cell Mass
Current Molecular Medicine Oxidative Stress, Inflammation and Endothelial Biomarkers in Arterial Hypertension
Current Hypertension Reviews TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
Current Pharmaceutical Design mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Inflammation, Serotonin and Major Depression
Current Drug Targets The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes
Reviews on Recent Clinical Trials Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Current Vascular Pharmacology Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury
Current Neurovascular Research Parasites in Rheumatoid Arthritis: Imminent Threat or Protective Effect?
Current Rheumatology Reviews The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications
Current Pharmaceutical Design Complications of Diabetes: An Insight into Genetic Polymorphism and Role of Insulin
Recent Patents on Inflammation & Allergy Drug Discovery Tyrosine Kinases and Inflammatory Signalling
Current Molecular Medicine Editorial [Hot Topic: How Brain Faces Stressors, Regulates Stress Response and Undergoes Stress Consequences (Guest Editor: Juan C. Leza)]
CNS & Neurological Disorders - Drug Targets Editorial: The Biologic Era: A Comprehensive Approach for Inflammatory and Immune-mediated Diseases
Current Pharmaceutical Biotechnology Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Recent Patents on Anti-Infective Drug Discovery Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates
Medicinal Chemistry